CD19 and neoplasm: We further extended our analysis of tumor cell-specific attributes through the evaluation of a second set of experiments, in which the immunologically inert human CD19 was ectopically expressed in the GL261-luc2 and CT2A-luc lines to provide a tumor-specific marker that facilitated cell sorting and characterization of the tumor cells (Cohort B, Figure 1A).